Biggest News Aggregation in the World
📰 Kzn News

Page 34 - Kzn News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Kzn. Real-time updates on events, politics, business and more.

Compugen To Receive $10 Mln Payment After Dosing First Patient In AstraZeneca's ARTEMIDE-Bil01 Trial

Cancer immunotherapy company Compugen Ltd. (CGEN) announced Monday that Compugen is entitled to receive a $10 million milestone payment from British drug major AstraZeneca (AZN), after the first patient was dosed in AstraZeneca's ARTEMIDE-Bil01 trial with rilvegostomig.
United Kingdom Compugen Ltd Drug Major Astrazeneca Ancer Immunotherapy Company Compugen

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science